Some breast cancers don't respond to chemotherapy
550207
An analysis of the results of  several studies confirm previous reports suggesting that  chemotherapy offers little or no survival benefits for young  women with estrogen receptor (ER)-positive breast cancers and,  if given, it should not be the sole second-phase, or "adjuvant"  therapy.
142045
Approximately half of the patients in the US with aggressive non-Hodgkin&#39;s lymphoma (NHL) are not receiving the full dose of chemotherapy that is recommended
47891
WEDNESDAY, Dec. 19 (HealthDay News) -- Most cancer specialists do not respond to the emotional concerns of their patients with verbal expressions of empathy and support, a new study reveals.
626880
NEW YORK  - In women with breast cancer,  the probability of dying from that malignancy, as opposed to  some other cause, can range from 3 percent to 85 percent,  depending on factors such as disease stage and patient age at  diagnosis, new research shows.
663608
Three quarters of women with terminal breast cancer receive no palliative care, according to a new study. Research published in the Journal of Clinical Oncology analysed the pattern of care at the end of life
638785
Dec.10, 2004 (San Antonio) -- A test that characterizes each breast tumor by its unique genetic fingerprint could spare tens of thousands of American women from the discomfort and misery of chemotherapy, researchers report.
330991
Doctors are missing key information they need to make decisions for cancer patients because some drug companies are not publishing clinical trials.
113005
More evidence that genetic tests can help predict whether breast cancer will recur could aid doctors and patients in deciding when to use chemotherapy.
631383
In women with breast cancer, the probability of dying from that malignancy, as opposed to some other cause, can range from 3 percent to 85 percent, depending on factors such as disease stage and patient age at diagnosis, new research shows.
373246
NEW YORK  - Treatment with clodronate does not improve survival in women with early or advanced breast cancer, according to the results of a meta-analysis of published studies.
79329
Some women with breast cancer are less likely to have their tumours picked up by scans, say experts.
450771
NEW YORK  - In general, chemotherapy  appears to increase the risk of stroke in patients with breast  cancer. However, researchers report in the October 20th issue  of the Journal of the National Cancer Institute.
743735
NEW YORK  - Women who undergo mastectomy  for breast cancer can have their breast rebuilt at the time of  surgery without delaying chemotherapy, if this treatment is  also needed, new research shows.
193007
NEW YORK  - Women who seek support in  coping with early-stage breast cancer through group counseling  sessions don't appear to improve their odds of surviving the  disease, new research indicates.
62192
Arimidex has been shown to reduce the recurrence of breast cancer in women better than tamoxifen, the standard breast cancer therapy for postmenopausal women.
415904
LONDON - Arimidex, one of a new class of breast cancer drugs, has clearly beaten standard treatment tamoxifen at preventing breast cancer from returning in a 5-year study, researchers said on Wednesday.
250736
WEDNESDAY, Dec. 26 (HealthDay News)-- Chemotherapy drugs known as anthracyclines help boost survival for women with HER2-positive breast cancer who have undergone surgery, but they may not offer any survival benefit for those with HER2-negative tumors.